148 related articles for article (PubMed ID: 27737600)
1. Update on bipolar disorder biomarker candidates.
Teixeira AL; Salem H; Frey BN; Barbosa IG; Machado-Vieira R
Expert Rev Mol Diagn; 2016 Nov; 16(11):1209-1220. PubMed ID: 27737600
[TBL] [Abstract][Full Text] [Related]
2. Novel biomarkers for bipolar disorder.
Teixeira AL; Barbosa IG; Machado-Vieira R; Rizzo LB; Wieck A; Bauer ME
Expert Opin Med Diagn; 2013 Mar; 7(2):147-59. PubMed ID: 23530885
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force.
Frey BN; Andreazza AC; Houenou J; Jamain S; Goldstein BI; Frye MA; Leboyer M; Berk M; Malhi GS; Lopez-Jaramillo C; Taylor VH; Dodd S; Frangou S; Hall GB; Fernandes BS; Kauer-Sant'Anna M; Yatham LN; Kapczinski F; Young LT
Aust N Z J Psychiatry; 2013 Apr; 47(4):321-32. PubMed ID: 23411094
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for bipolar disorder: current status and challenges ahead.
Teixeira AL; Colpo GD; Fries GR; Bauer IE; Selvaraj S
Expert Rev Neurother; 2019 Jan; 19(1):67-81. PubMed ID: 30451546
[TBL] [Abstract][Full Text] [Related]
5. Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals.
Steardo L; Manchia M; Carpiniello B; Pisanu C; Steardo L; Squassina A
Expert Rev Mol Diagn; 2020 Mar; 20(3):327-333. PubMed ID: 32054361
[No Abstract] [Full Text] [Related]
6. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value.
Ribeiro HC; Zandonadi FDS; Sussulini A
Expert Rev Proteomics; 2023; 20(11):267-280. PubMed ID: 37830362
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.
Pfaffenseller B; Fries GR; Wollenhaupt-Aguiar B; Colpo GD; Stertz L; Panizzutti B; Magalhães PV; Kapczinski F
Expert Rev Neurother; 2013 Jul; 13(7):827-42. PubMed ID: 23898853
[TBL] [Abstract][Full Text] [Related]
8. Biological hypotheses and biomarkers of bipolar disorder.
Sigitova E; Fišar Z; Hroudová J; Cikánková T; Raboch J
Psychiatry Clin Neurosci; 2017 Feb; 71(2):77-103. PubMed ID: 27800654
[TBL] [Abstract][Full Text] [Related]
9. Corticolimbic connectivity as a possible biomarker for bipolar disorder.
Vai B; Bollettini I; Benedetti F
Expert Rev Neurother; 2014 Jun; 14(6):631-50. PubMed ID: 24852228
[TBL] [Abstract][Full Text] [Related]
10. Potential biomarkers for bipolar disorder: Where do we stand?
Sagar R; Pattanayak RD
Indian J Med Res; 2017 Jan; 145(1):7-16. PubMed ID: 28574009
[TBL] [Abstract][Full Text] [Related]
11. Bipolar disorder: recent advances and future trends in bioanalytical developments for biomarker discovery.
de Jesus JR; de Campos BK; Galazzi RM; Martinez JL; Arruda MA
Anal Bioanal Chem; 2015 Jan; 407(3):661-7. PubMed ID: 25433685
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and clinical implications of functional neuroimaging in bipolar disorder.
Brooks JO; Vizueta N
J Psychiatr Res; 2014 Oct; 57():12-25. PubMed ID: 25015683
[TBL] [Abstract][Full Text] [Related]
13. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
14. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder.
Kapczinski F; Dias VV; Kauer-Sant'Anna M; Brietzke E; Vázquez GH; Vieta E; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1366-71. PubMed ID: 19666076
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
16. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines as an underlying mechanism of the comorbidity between bipolar disorder and migraine.
Brietzke E; Mansur RB; Grassi-Oliveira R; Soczynska JK; McIntyre RS
Med Hypotheses; 2012 May; 78(5):601-5. PubMed ID: 22365650
[TBL] [Abstract][Full Text] [Related]
18. Toward stratified treatments for bipolar disorders.
Hasler G; Wolf A
Eur Neuropsychopharmacol; 2015 Mar; 25(3):283-94. PubMed ID: 25595029
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
Martin C; Tansey KE; Schalkwyk LC; Powell TR
Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies.
Ghanizadeh A; Singh AB; Berk M; Torabi-Nami M
Expert Opin Ther Targets; 2015 Jul; 19(7):927-39. PubMed ID: 25882812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
